Enews from the Alzheimer's Association
Having trouble viewing this message? You may view it as a web page. You may also view e-news archives.
To prevent mailbox filters from deleting your Alzheimer's Association email communications, please add alzheimers_enews@alz.org to your address book.
December 14, 2016
24/7 Helpline: 800.272.3900
Experts have hope for an Alzheimer’s drug to be developed by 2025
Experts believe that some form of a new Alzheimer’s drug will be developed by 2025, despite negative results of recent Alzheimer’s disease clinical trials. Leading scientists believe there is still great hope for novel therapies in the relative short term, most likely pilot versions that will need to be upgraded.

Click here to read more
Register today for the 2017 Alzheimer’s Association Advocacy Forum
The relentless efforts of advocates of the Alzheimer’s Association and the Alzheimer's Impact Movement, our sister organization, have resulted in historic Alzheimer’s research funding increases at the National Institutes of Health and greater access to care and support services. But with a new administration and a new Congress on the way, there’s more critical work to be done. Join us at the 2017 Alzheimer’s Association Advocacy Forum March 27-29 to learn about the global and national impact of Alzheimer’s and how to deliver our powerful messages to elected officials.
Click here to read more
Online Tools
Your Local Community
 
 
Devine Color by Valspar joins in the fight to end Alzheimer’s
Devine Color by Valspar paint, developed by artist Gretchen Schauffler, reflects Schauffler’s belief that color can enhance mood. Her latest work includes creating colorfully pleasing environments for aging adults and helping improve the lives of people living with Alzheimer’s disease through Devine Color’s support of the Alzheimer’s Association. Valspar will donate $25,000 to the Association by Jan. 31, 2017.
Click here to read more
Your donations and support make a difference.
More Resources: 
Behaviors  | 
The Alzheimer's Association is the leading voluntary health organization in Alzheimer's care, support and research. Our mission is to eliminate Alzheimer's disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health.

Alzheimer's Association National Office 225 N. Michigan Ave., Fl. 17, Chicago, IL 60601
© 2016 Alzheimer's Association. All rights reserved. www.alz.org | 800.272.3900
To change your email preferences click here.